PROTAGONIST THERAPEUTICS INC (PTGX) Institutional Ownership Changes & 13F Activity

PROTAGONIST THERAPEUTICS INC (PTGX). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings. This page analyzes institutional buying and selling activity, new holdings, and sold-out positions among tracked filers. Notable filers include Polen Capital Management and Renaissance Technologies LLC.

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q2 2017Renaissance Technologies LLCBuy25,98925,989$294

Frequently asked questions about PTGX activity

  • Which institutional owners are buying PTGX?

    Institutional owners buying PTGX include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in PTGX activity?

    "Buy" means an investor increased their reported position in PTGX compared to the prior reporting period. This reflects growing exposure to PROTAGONIST THERAPEUTICS INC (PTGX) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in PTGX increasing?

    Institutional interest in PTGX can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.

Related PTGX Institutional Insights